Cervical Cancer Prevention
Conditions
Brief summary
The goal of this clinical trial is identify an effective and implementable set of implementation strategies to increase cervical cancer prevention in Malawi. The main questions it aims to answer are: 1. Which implementation strategies produce the greatest increase in provider recommendation for, and uptake of, cervical cancer prevention tools among people receiving HIV care. 2. What is the acceptability, appropriateness, feasibility, and cost of these implementation strategies. 3. What is the sustained effect of these implementation strategies. The implementation strategies will be conducted with health workers (clinical officers, nurses, and medical assistants): training, coaching, and a reminder system.
Interventions
BEHAVIORALIn-person training
An in-person educational session.
BEHAVIORALVirtual training
A virtual educational session.
BEHAVIORALCoaching
Short video vignettes plus reinforcing messages
BEHAVIORALPrompts
Visual aide to remind providers to discuss cervical cancer prevention methods.
Sponsors
New York University
National Cancer Institute (NCI)
University of California, Los Angeles
Partners in Hope, Inc.
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
9 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Health workers: People who provide medical care and counseling (typically medical assistants, clinical officers, and nurses), and interact with adolescent girls and young women aged 9-24 and/or their parents/caregivers. * Clients: Non-pregnant females aged 9-24 (for those aged 9-17, their male or female parent/guardian will also be eligible for participation) who present for HIV care at a participating health facility during the study period.
Exclusion criteria
* Health workers: Less than 18 years of age, or not an active and regular provider of medical care or counseling at the facility, or unable or unwilling to provide informed consent. * Clients: \<9 or \>24 years old, or pregnancy, or unable or unwilling to provide informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Difference in prevalence of discussions surrounding methods of cervical cancer prevention | Months 7-18 | Discussions about methods of cervical cancer prevention will be reported by clients following each routine HIV care visit. This rate is defined as the percentage of visits during which there is a discussion about methods of cervical cancer prevention. This rate will be compared between the groups with and without each intervention component. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Difference in prevalence of completing a cervical cancer prevention program | Months 7-18 | Completing a cervical cancer prevention program will be reported by clients following each routine HIV care visit. This prevalence is defined as the percentage of clients who complete a cervical cancer prevention program. This prevalence will be compared between the groups with and without each intervention component. |
| Difference in prevalence of initiating a cervical cancer prevention program among those uninitiated | Months 7-18 | This prevalence is defined among those who have not begun a cervical cancer prevention program at study entry. This prevalence will be compared between the groups with and without each intervention component. |
Countries
Malawi
Contacts
PRINCIPAL_INVESTIGATORCorrina Moucheraud
New York University
PRINCIPAL_INVESTIGATORRisa M Hoffman
University of California, Los Angeles
PRINCIPAL_INVESTIGATORSam Phiri
Partners in Hope, Inc.
Outcome results
None listed